Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
Bicycle Therapeutics Plc ADR (NASDAQ: BCYC) closed the day trading at $19.21 down -2.39% from the previous closing price of $19.68. In other words, the price has decreased by -$2.39 from its previous closing price. On the day, 0.66 million shares were traded. BCYC stock price reached its highest trading level at $19.85 during the session, while it also had its lowest trading level at $18.88.
Ratios:
For a better understanding of BCYC, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.13 and its Current Ratio is at 17.13. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on November 08, 2024, initiated with a Equal-Weight rating and assigned the stock a target price of $25.
On September 06, 2024, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $35.
B. Riley Securities Downgraded its Buy to Neutral on August 07, 2024, whereas the target price for the stock was revised from $33 to $28.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 11 ’24 when Thompson Travis Alvin sold 6,256 shares for $25.11 per share. The transaction valued at 157,114 led to the insider holds 19,241 shares of the business.
Thompson Travis Alvin bought 6,256 shares of BCYC for $157,112 on Nov 11 ’24. On Oct 03 ’24, another insider, Lee Kevin, who serves as the CHIEF EXECUTIVE OFFICER of the company, sold 3,212 shares for $22.26 each. As a result, the insider received 71,499 and left with 380,864 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCYC now has a Market Capitalization of 1326373632 and an Enterprise Value of 446599072. For the stock, the TTM Price-to-Sale (P/S) ratio is 35.86 while its Price-to-Book (P/B) ratio in mrq is 1.60. Its current Enterprise Value per Revenue stands at 12.104 whereas that against EBITDA is -2.359.
Stock Price History:
Over the past 52 weeks, BCYC has reached a high of $28.67, while it has fallen to a 52-week low of $14.33. The 50-Day Moving Average of the stock is -17.35%, while the 200-Day Moving Average is calculated to be -17.20%.
Shares Statistics:
Over the past 3-months, BCYC traded about 464.85K shares per day on average, while over the past 10 days, BCYC traded about 437760 shares per day. A total of 69.02M shares are outstanding, with a floating share count of 65.57M. Insiders hold about 4.99% of the company’s shares, while institutions hold 55.66% stake in the company. Shares short for BCYC as of 1731628800 were 3524722 with a Short Ratio of 7.58, compared to 1728950400 on 2920494. Therefore, it implies a Short% of Shares Outstanding of 3524722 and a Short% of Float of 7.99.
